6th July 2023
For US-based companies seeking to market their product in the EU, it can be a struggle to navigate a different market, and, in particular, to manage requirements from a safety reporting perspective. The podcast explores the challenges faced managing not only the European pharmacovigilance legislation but also dealing with each EU Member State, which can implement these requirements in their own way at the national level.
Bios:
Monica Buchberger is senior director of pharmacovigilance at PharmaLex, drawing on her many years in industry in pharmacovigilance and regulatory roles, including quality assurance systems and serving as the EU QPPV for Abbott Laboratories.
Stephen Sun is a physician by training who heads up the US pharmacovigilance team for global PharmaLex and is also the service area head for benefit-risk management.
Listen to the episode now on the PharmaLex Talks website.
22nd February 2024
25th September 2023
6th July 2023
31st January 2023
17th May 2022
8th April 2022
23rd February 2022
1st December 2021
1st June 2021
5th February 2020
8th March 2018